Please assess the completion status of the following clinical trial:

Trial Title: Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy, reproductive age women~* 18 to 35 years old,~* seeking contraception from the general gynecology clinics of the LAC and USC Medical Center w~* taking one of 6 possible monophasic COC formulations for at least 3 cycles prior to enrollment~* regular menstrual cycles prior to COCs~Exclusion Criteria:~* Irregular bleeding~* bilateral oophorectomy~* amenorrhea~* hormone-sensitive cancer~* concurrent medications known to interfere with steroid metabolism (i.e., barbiturates, phenytoin, carbamazepine, ethosuximide, primidone, rifampin, tetracycline)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: None

Study Arms:
- Healthy reproductive age women (Type: None): These volunteers were previously taking the oral contraceptives of interest for a minimum of 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).